Erythema multiforme: As a complication of allergen-specific immunotherapy

Allergol Immunopathol (Madr). 2001 Nov-Dec;29(6):276-8. doi: 10.1016/s0301-0546(01)79070-2.

Abstract

Here we present a 25-year-old female patient admitted with a complaint of blistering lesions on her face, neck, chest and extremities appearing after the first dosis of specific immunotherapy and diagnosed as erythema multiforme. To our knowledge, there are no papers in the literature reporting erythema multiforme due to specific immunotherapy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Allergens / adverse effects*
  • Allergens / therapeutic use
  • Animals
  • Antigens, Dermatophagoides
  • Antigens, Fungal / adverse effects*
  • Antigens, Fungal / therapeutic use
  • Desensitization, Immunologic / adverse effects*
  • Erythema Multiforme / drug therapy
  • Erythema Multiforme / etiology*
  • Female
  • Fungi / immunology
  • Glycoproteins / adverse effects*
  • Glycoproteins / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Mites / immunology
  • Prednisolone / therapeutic use
  • Rhinitis, Allergic, Perennial / therapy

Substances

  • Allergens
  • Antigens, Dermatophagoides
  • Antigens, Fungal
  • Glycoproteins
  • Immunosuppressive Agents
  • Prednisolone